Medicare Enrolled
Dr. George Howard, M.D.
Hematology & Oncology · Sterling Heights, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Howard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Howard?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Howard
Dr. George Howard is a hematology & oncology specialist in Sterling Heights, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Howard performed 111,283 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Howard received a total of $26,507 from 67 pharmaceutical and/or device companies across 403 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Howard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 4% volume in MI
$26,507 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗111,283
Medicare services
Top 4% in MI for hematology & oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
58,650 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 14,800 | $39 | $69 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
11,600 | $0 | $0 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,250 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 5,220 | $18 | $25 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
2,190 | $22 | $100 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,920 | $6 | $18 |
| Injection, granisetron hydrochloride, 100 mcg | 1,690 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,676 | $0 | $2 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
993 | $8 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
958 | $8 | $25 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
593 | $12 | $50 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
576 | $77 | $342 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
571 | $97 | $176 |
| Anti-nausea injection (Aloxi/palonosetron) | 400 | $1 | $5 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
378 | $2 | $10 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 336 | $3 | $20 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
334 | $102 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
326 | $96 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
266 | $136 | $225 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
248 | $11 | $40 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
228 | $2 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
178 | $66 | $125 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
171 | $23 | $75 |
| Injection, leucovorin calcium, per 50 mg | 159 | $3 | $10 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
150 | $58 | $150 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
141 | $50 | $150 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
138 | $10 | $35 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
132 | $51 | $125 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
127 | $140 | $275 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
118 | $1 | $2 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
101 | $1 | $6 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
84 | $1 | $10 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
78 | $23 | $65 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
67 | $10 | $50 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
63 | $24 | $100 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
56 | $2 | $5 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
48 | $44 | $125 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
43 | $124 | $450 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
42 | $20 | $50 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
42 | $15 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $120 | $250 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
30 | $78 | $175 |
| New patient office visit, complex (60-74 min) | 25 | $165 | $305 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
21 | $19 | $50 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
16 | $64 | $100 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
11 | $93 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
53.4% high complexity
43.1% medium
3.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$26,507
Total received (2018-2024)
Avg $3,787/year across 7 years
Top 8% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
403
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$479
2023
$2,531
2022
$1,589
2021
$933
2020
$549
2019
$452
2018
$19,974
Payments by company (2024)
BeiGene USA, Inc.
$64
ABBVIE INC.
$56
GENZYME CORPORATION
$47
Adaptive Biotechnologies Corporation
$44
Takeda Pharmaceuticals U.S.A., Inc.
$35
SERVIER PHARMACEUTICALS LLC
$33
Merck Sharp & Dohme LLC
$33
AstraZeneca Pharmaceuticals LP
$28
Boston Scientific Corporation
$27
JAZZ PHARMACEUTICALS INC.
$25
Genentech USA, Inc.
$22
Janssen Biotech, Inc.
$22
Celgene Corporation
$21
Daiichi Sankyo Inc.
$19
ARRAY BIOPHARMA INC
$2
Top 3 companies account for 34.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$7,985
Gilead Sciences, Inc.
$5,414
PFIZER INC.
$5,399
Pharmacyclics LLC, An AbbVie Company
$1,217
Amgen Inc.
$1,179
Genentech USA, Inc.
$504
GENZYME CORPORATION
$396
Seagen Inc.
$252
Novartis Pharmaceuticals Corporation
$245
Astellas Pharma US Inc
$236
Exelixis Inc.
$223
Incyte Corporation
$193
Celgene Corporation
$180
JAZZ PHARMACEUTICALS INC.
$179
AstraZeneca Pharmaceuticals LP
$175
G1 Therapeutics, Inc.
$151
Focal Therapeutics, Inc.
$129
BeiGene USA, Inc.
$127
Kite Pharma, Inc.
$126
Merck Sharp & Dohme LLC
$114
Eisai Inc.
$112
ABBVIE INC.
$110
Bayer Healthcare Pharmaceuticals Inc.
$106
SANOFI-AVENTIS U.S. LLC
$99
EMD Serono, Inc.
$99
Daiichi Sankyo Inc.
$99
Takeda Pharmaceuticals U.S.A., Inc.
$97
Lilly USA, LLC
$95
Adaptive Biotechnologies Corporation
$88
Ipsen Biopharmaceuticals, Inc
$87
Mirati Therapeutics, Inc.
$84
E.R. Squibb & Sons, L.L.C.
$68
Rigel Pharmaceuticals, Inc.
$56
SERVIER PHARMACEUTICALS LLC
$53
TerSera Therapeutics LLC
$44
Stemline Therapeutics Inc.
$43
Blueprint Medicines Corporation
$42
Sumitomo Pharma America, Inc.
$39
Pharmacyclics LLC, an AbbVie Company
$37
Janssen Pharmaceuticals, Inc
$34
Alnylam Pharmaceuticals Inc.
$33
ARRAY BIOPHARMA INC
$32
SOBI, INC
$30
Kyowa Kirin, Inc.
$29
AVEO Pharmaceuticals, Inc.
$29
AMAG Pharmaceuticals, Inc.
$27
Heron Therapeutics, Inc.
$27
Boston Scientific Corporation
$27
Karyopharm Therapeutics Inc.
$25
PharmaEssentia USA Corporation
$25
EUSA Pharma (US) LLC
$24
RECORDATI_RARE_DISEASES_INC.
$24
Jazz Pharmaceuticals Inc.
$24
GlaxoSmithKline, LLC.
$22
Myovant Sciences Inc.
$22
Merck Sharp & Dohme Corporation
$21
Bayer HealthCare Pharmaceuticals Inc.
$19
Pharmacosmos Therapeutics Inc.
$18
AbbVie, Inc.
$17
Deciphera Pharmaceuticals Inc.
$17
Immunomedics, Inc.
$17
Sobi, Inc
$15
Spectrum Pharmaceuticals Inc.
$15
MorphoSys, US Inc.
$15
Octapharma USA, Inc.
$15
Aveo Pharmaceuticals, Inc.
$12
Puma Biotechnology, Inc.
$12
Top 3 companies account for 70.9% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AYVAKIT · Alecensa · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · BioZorb · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · FARESTON · FERAHEME · FOTIVDA · FRUZAQLA · GAZYVA · GIVLAARI · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · ORGOVYX · Onivyde · Orserdu · PADCEV · PANHEMATIN · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Stivarga · Sylvant · TALZENNA · TASIGNA · TECENTRIQ · TEPMETKO · TUKYSA · Tavalisse · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · Tibsovo · Trodelvy · VENCLEXTA · VERZENIO · VPRIV · VYXEOS · Vanflyta · Vectibix · Venclexta · Voranigo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEPZELCA · Zydelig · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
120
County median income
$76,399
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL, TROY
3.5 mi
3.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Howard is a mixed practice specialist, with above-average Medicare volume (top 4% in MI), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Howard experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Howard performed 58,650 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Howard receive payments from pharmaceutical companies?
Yes. Dr. Howard received a total of $26,507 from 67 companies across 403 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Howard's costs compare to other hematology & oncology specialists in Sterling Heights?
Dr. Howard's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Howard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Sterling Heights
Browse hematology & oncology specialists in Sterling Heights ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology